Reference SummaryFijneman RJ, Oncogene 1994 May;9(5):1417-21
Title |
Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation. |
Authors |
Fijneman RJ; Ophoff RA; Hart AA; Demant P |
Journal |
Oncogene |
Volume |
9 |
Issue |
5 |
Year |
1994 |
Pages |
1417-21 |
Abstract |
Lung Tumor Susceptibility (LTS) in the mouse has been shown to be influenced by loci within the Major Histocompatibility Complex (MHC) and the Kras-2 regions. In crosses between susceptible and resistant strains, one allele of Kras-2 has been linked with a high LTS, whereas the other allele has been linked with a low LTS. Furthermore, these Kras-2 alleles affect differently the occurrence of Kras-2 mutations in lung tumors. In this study we evaluated the relationship between LTS, Kras-2 alleles and Kras-2 mutations, using Recombinant Congenic Strains with identical MHC haplotypes. The Kras-2 region indeed influences the frequency of Kras-2 mutations in N-ethyl-N-nitrosourea-induced lung tumors. These mutations are associated with larger tumors. However, Kras-2 affects LTS only marginally. Several strains with identical Kras-2 alleles and mutation frequency differ widely in LTS, while some strains with different alleles and mutation frequency do not. We conclude that a considerable part of the genetic variability in LTS is caused by LTS-loci other than Kras-2 and MHC. |
Links |
J:17850 – MGI References 8152802 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
O20 | Lung tumor |
|
Lung |
66 |
|
B10.O20-H2pz | Lung tumor |
|
Lung |
34 |
|
OcB9/Dem | Lung tumor |
|
Lung |
59 |
|
OcB6/Dem | Lung tumor |
|
Lung |
61 |
|
OcB15/Dem | Lung tumor |
|
Lung |
50 |